# Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

> **NCT00813787** · — · UNKNOWN · sponsor: **AHS Cancer Control Alberta** · enrollment: 20 (estimated)

## Conditions studied

- Glioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00813787
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-02
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813787, "Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00813787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*